APA

Kuiper J. L., Ronden M. I., Becker A., Heideman D. A. M., van Hengel P., Ylstra B., Thunnissen E. & Smit E. F. (20150520). Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor. : Journal of clinical pathology.

Chicago

Kuiper Justine L, Ronden Merle I, Becker Annemarie, Heideman Daniëlle A M, van Hengel Peter, Ylstra Bauke, Thunnissen Erik and Smit Egbert F. 20150520. Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor. : Journal of clinical pathology.

Harvard

Kuiper J. L., Ronden M. I., Becker A., Heideman D. A. M., van Hengel P., Ylstra B., Thunnissen E. and Smit E. F. (20150520). Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor. : Journal of clinical pathology.

MLA

Kuiper Justine L, Ronden Merle I, Becker Annemarie, Heideman Daniëlle A M, van Hengel Peter, Ylstra Bauke, Thunnissen Erik and Smit Egbert F. Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor. : Journal of clinical pathology. 20150520.